Found: 34
Select item for more details and to access through your institution.
Temozolomide in the treatment of an invasive prolactinoma resistant to dopamine agonists.
- Published in:
- 2007
- By:
- Publication type:
- Report
Drug Screening of Human GBM Spheroids in Brain Cancer Chip.
- Published in:
- Scientific Reports, 2018, v. 8, n. 1, p. 1, doi. 10.1038/s41598-018-33641-2
- By:
- Publication type:
- Article
Phospholipase C Beta 1: a Candidate Signature Gene for Proneural Subtype High-Grade Glioma.
- Published in:
- Molecular Neurobiology, 2016, v. 53, n. 9, p. 6511, doi. 10.1007/s12035-015-9518-2
- By:
- Publication type:
- Article
Rapid detection of mutations in CSF-cfTNA with the Genexus Integrated Sequencer.
- Published in:
- Journal of Neuro-Oncology, 2024, v. 166, n. 1, p. 39, doi. 10.1007/s11060-023-04487-0
- By:
- Publication type:
- Article
Postmortem study of organ-specific toxicity in glioblastoma patients treated with a combination of temozolomide, irinotecan and bevacizumab.
- Published in:
- Journal of Neuro-Oncology, 2022, v. 160, n. 1, p. 221, doi. 10.1007/s11060-022-04144-y
- By:
- Publication type:
- Article
IDH1 p.R132H ctDNA and D-2-hydroxyglutarate as CSF biomarkers in patients with IDH-mutant gliomas.
- Published in:
- Journal of Neuro-Oncology, 2022, v. 159, n. 2, p. 261, doi. 10.1007/s11060-022-04060-1
- By:
- Publication type:
- Article
Impacts of genotypic variants on survival following reoperation for recurrent glioblastoma.
- Published in:
- Journal of Neuro-Oncology, 2022, v. 156, n. 2, p. 353, doi. 10.1007/s11060-021-03917-1
- By:
- Publication type:
- Article
PTEN mutations predict benefit from tumor treating fields (TTFields) therapy in patients with recurrent glioblastoma.
- Published in:
- Journal of Neuro-Oncology, 2021, v. 153, n. 1, p. 153, doi. 10.1007/s11060-021-03755-1
- By:
- Publication type:
- Article
Genomic alterations predictive of response to radiosurgery in recurrent IDH-WT glioblastoma.
- Published in:
- Journal of Neuro-Oncology, 2021, v. 152, n. 1, p. 153, doi. 10.1007/s11060-020-03689-0
- By:
- Publication type:
- Article
Correction to: Global post‑marketing safety surveillance of Tumor Treating Fields (TTFields) in patients with high‑grade glioma in clinical practice.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Additional genetic alterations in BRAF-mutant gliomas correlate with histologic diagnoses.
- Published in:
- Journal of Neuro-Oncology, 2020, v. 149, n. 3, p. 463, doi. 10.1007/s11060-020-03634-1
- By:
- Publication type:
- Article
Global post-marketing safety surveillance of Tumor Treating Fields (TTFields) in patients with high-grade glioma in clinical practice.
- Published in:
- Journal of Neuro-Oncology, 2020, v. 148, n. 3, p. 489, doi. 10.1007/s11060-020-03540-6
- By:
- Publication type:
- Article
Health-related quality of life, cognitive screening, and functional status in a randomized phase III trial (EF-14) of tumor treating fields with temozolomide compared to temozolomide alone in newly diagnosed glioblastoma.
- Published in:
- Journal of Neuro-Oncology, 2017, v. 135, n. 3, p. 545, doi. 10.1007/s11060-017-2601-y
- By:
- Publication type:
- Article
Analysis of the BRCA1 and BRCA2 genes in sporadic meningiomas.
- Published in:
- Genes, Chromosomes & Cancer, 1997, v. 20, n. 1, p. 53, doi. 10.1002/(SICI)1098-2264(199709)20:1<53::AID-GCC8>3.0.CO;2-8
- By:
- Publication type:
- Article
Maintenance Therapy With Tumor-Treating Fields Plus Temozolomide vs Temozolomide Alone for Glioblastoma: A Randomized Clinical Trial.
- Published in:
- 2015
- By:
- Publication type:
- journal article
The genomic alterations in glioblastoma influence the levels of CSF metabolites.
- Published in:
- Acta Neuropathologica Communications, 2024, v. 12, n. 1, p. 1, doi. 10.1186/s40478-024-01722-1
- By:
- Publication type:
- Article
NF-κB inhibitor with Temozolomide results in significant apoptosis in glioblastoma via the NF-κB(p65) and actin cytoskeleton regulatory pathways.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41598-020-70392-5
- By:
- Publication type:
- Article
The relationship between plasma amyloid-β peptides and the medial temporal lobe in the homebound elderly.
- Published in:
- 2011
- By:
- Publication type:
- journal article
The relationship between plasma amyloid-β peptides and the medial temporal lobe in the homebound elderly.
- Published in:
- International Journal of Geriatric Psychiatry, 2011, v. 26, n. 6, p. 593, doi. 10.1002/gps.2568
- By:
- Publication type:
- Article
Presence of complete murine viral genome sequences in patient-derived xenografts.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-22200-5
- By:
- Publication type:
- Article
Analysis of cerebrospinal fluid metabolites in patients with primary or metastatic central nervous system tumors.
- Published in:
- Acta Neuropathologica Communications, 2018, v. 6, n. 1, p. N.PAG, doi. 10.1186/s40478-018-0588-z
- By:
- Publication type:
- Article
Cerebrospinal fluid ctDNA and metabolites are informative biomarkers for the evaluation of CNS germ cell tumors.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. N.PAG, doi. 10.1038/s41598-020-71161-0
- By:
- Publication type:
- Article
Assessment of Glioblastoma Response in the Era of Bevacizumab: Longstanding and Emergent Challenges in the Imaging Evaluation of Pseudoresponse.
- Published in:
- Frontiers in Neurology, 2019, p. N.PAG, doi. 10.3389/fneur.2019.00460
- By:
- Publication type:
- Article
Triple-drug Therapy With Bevacizumab, Irinotecan, and Temozolomide Plus Tumor Treating Fields for Recurrent Glioblastoma: A Retrospective Study.
- Published in:
- Frontiers in Neurology, 2019, p. N.PAG, doi. 10.3389/fneur.2019.00042
- By:
- Publication type:
- Article
LILRB2-mediated TREM2 signaling inhibition suppresses microglia functions.
- Published in:
- Molecular Neurodegeneration, 2022, v. 17, n. 1, p. 1, doi. 10.1186/s13024-022-00550-y
- By:
- Publication type:
- Article
Impact of timing to initiate adjuvant therapy on survival of elderly glioblastoma patients using the SEER-Medicare and national cancer databases.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-30017-z
- By:
- Publication type:
- Article
Corrigendum: Efficacy and Safety of Tumor Treating Fields (TTFields) in Elderly Patients With Newly Diagnosed Glioblastoma: Subgroup Analysis of methe Phase 3 EF-14 Clinical Trial.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Efficacy and Safety of Tumor Treating Fields (TTFields) in Elderly Patients with Newly Diagnosed Glioblastoma: Subgroup Analysis of the Phase 3 EF-14 Clinical Trial.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.671972
- By:
- Publication type:
- Article
The Use of Apparent Diffusion Coefficient Values for Differentiating Bevacizumab-Related Cytotoxicity from Tumor Recurrence and Radiation Necrosis in Glioblastoma.
- Published in:
- Cancers, 2024, v. 16, n. 13, p. 2440, doi. 10.3390/cancers16132440
- By:
- Publication type:
- Article
Adjuvant Gamma Knife radiosurgery following surgical resection of brain metastases: a 9-year retrospective cohort study.
- Published in:
- Journal of Neuro-Oncology, 2010, v. 98, n. 1, p. 77, doi. 10.1007/s11060-009-0051-x
- By:
- Publication type:
- Article
Detection of the MYD88 p.L265P Mutation in the CSF of a Patient With Secondary Central Nervous System Lymphoma.
- Published in:
- Frontiers in Oncology, 2018, p. N.PAG, doi. 10.3389/fonc.2018.00382
- By:
- Publication type:
- Article
EPID-01. ASSOCIATIONS OF TIMING OF ADJUVANT THERAPIES, RADIATION FRACTIONS AND RADIATION DOSES WITH GLIOBLASTOMA SURVIVAL: A RETROSPECTIVE COHORT ANALYSIS USING THE NATIONAL CANCER DATABASE AND SEER-MEDICARE DATABASE.
- Published in:
- Neuro-Oncology, 2018, v. 20, p. vi80, doi. 10.1093/neuonc/noy148.328
- By:
- Publication type:
- Article
ZIP4 is a novel molecular marker for glioma.
- Published in:
- Neuro-Oncology, 2013, v. 15, n. 8, p. 1008, doi. 10.1093/neuonc/not042
- By:
- Publication type:
- Article
Phase 2 study of dose-intense temozolomide in recurrent glioblastoma.
- Published in:
- Neuro-Oncology, 2013, v. 15, n. 7, p. 930, doi. 10.1093/neuonc/not040
- By:
- Publication type:
- Article